EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Innovative Dual mRNA-Lipid Nanoparticle Therapy Targeting CRHBP and CFHR3 for Enhanced Treatment of Hepatocellular Carcinoma

Tianmei Fu, Boxuan Zhou, Yingliang Li, Wei Liu, Yuankang Xie, Zhaohong Mo, Fang Yin, Yu Wang, Kang Fang, Yangyang Fang, Ziqing Xiong, Kuai Yu und 1 weitere

International Journal of Nanomedicine · 2024

DOI: 10.2147/ijn.s498065 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Nanomedicine, 2024. Verfasst von Tianmei Fu und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Transfusion Medicine, Key Laboratory of Jiangxi Province for Transfusion Medicine, The First Affiliated Hospital, Jiangxi Medical Colle…. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Nanoparticles, RNA, Messenger. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsNanoparticlesRNA, MessengerAnimalsHumansMiceCell Line, TumorMaleFemaleMice, NudeLiposomesMice, Inbred BALB CXenograft Model Antitumor Assays

Stichwörter der Autor:innen

CFHR3CRHBPLipid nanoparticlesmRNA

Substanzen

RNA, MessengerLipid NanoparticlesLiposomes

Autor:innen und Institutionen

  • Department of Transfusion Medicine, Key Laboratory of Jiangxi Province for Transfusion Medicine, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, People's Republic of China.
  • Department of Breast Disease Center, the First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, People's Republic of China.
  • Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital of Gannan Medical University, Ganzhou, People's Republic of China.
  • Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanchang, People's Republic of China.
  • Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, People's Republic of China.

Zitieren

APA

Fu, T., Zhou, B., Li, Y., Liu, W., Xie, Y., Mo, Z., Yin, F., Wang, Y., Fang, K., Fang, Y., Xiong, Z., Yu, K., & Le, A. (2024). Innovative Dual mRNA-Lipid Nanoparticle Therapy Targeting CRHBP and CFHR3 for Enhanced Treatment of Hepatocellular Carcinoma. International Journal of Nanomedicine. https://doi.org/10.2147/ijn.s498065

Vancouver

Fu T, Zhou B, Li Y, Liu W, Xie Y, Mo Z, et al. Innovative Dual mRNA-Lipid Nanoparticle Therapy Targeting CRHBP and CFHR3 for Enhanced Treatment of Hepatocellular Carcinoma. International Journal of Nanomedicine. 2024. doi:10.2147/ijn.s498065

BibTeX
@article{Fu2024,
  author = {Fu, Tianmei and Zhou, Boxuan and Li, Yingliang and Liu, Wei and Xie, Yuankang and Mo, Zhaohong and Yin, Fang and Wang, Yu and Fang, Kang and Fang, Yangyang and Xiong, Ziqing and Yu, Kuai and Le, Aiping},
  title = {Innovative Dual mRNA-Lipid Nanoparticle Therapy Targeting CRHBP and CFHR3 for Enhanced Treatment of Hepatocellular Carcinoma},
  journal = {International Journal of Nanomedicine},
  year = {2024},
  doi = {10.2147/ijn.s498065}
}
Kostenlos starten →